(Q39576406)

reason for preferred rank

13 September 2017

title

Treatment of Paget's Disease with the Calcitonins* (English)

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1979.TB04110.X

23 February 2023

Treatment of Paget's disease with the calcitonins (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A287441

23 February 2023

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1979.TB04110.X

23 February 2023

author name string

T. J. Martin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A287441

23 February 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=287441

23 February 2023

publication date

1 February 1979

1 reference

full work available at URL

13 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1445-5994.1979.tb04110.x

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1979.TB04110.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1445-5994.1979.tb04110.x/fullpdf

23 February 2023

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1979.TB04110.X

Australian and New Zealand journal of medicine

23 February 2023

published in

1 reference

13 September 2017

volume

9

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

36-43

1 reference

Clinical, Biochemical and Histological Observations on the Effect of Porcine Calcitonin in Paget's Disease of Bone*

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1979.TB04110.X

Calcitonin Production and the Mitochondrion-Rich Cells of the Dog Thyroid

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1979.TB04110.X

Calcitonin from Ultimobranchial Glands of Dogfish and Chickens

23 February 2023

2

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1979.TB04110.X

Thyrocalcitonin: inhibitor of bone resorption in tissue culture

23 February 2023

3

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1979.TB04110.X

The mode of action of thyrocalcitonin

23 February 2023

4

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1979.TB04110.X

An Improved Method for the Biological Assay of Thyrocalcitonin

23 February 2023

5

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1979.TB04110.X

The acute effects of porcine calcitonin in man

23 February 2023

6

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1979.TB04110.X

Effects of calcitonin on patients with Paget's disease, thyrotoxicosis, or hypercalcaemia

23 February 2023

8

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1979.TB04110.X

Human calcitonin in the treatment of Paget's bone disease

23 February 2023

9

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1979.TB04110.X

Radiological evidence of a dose-related response to long-term treatment of Paget's disease with human calcitonin

23 February 2023

10

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1979.TB04110.X

Paget's disease of bone; incidence and subclinical forms

23 February 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1979.TB04110.X

The Therapeutic Uses of Calcitonin

23 February 2023

15

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1979.TB04110.X

Long term studies of the blood chemistry in Paget's disease of bone

23 February 2023

16

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1979.TB04110.X

Cardiac output in Paget's disease: response to long-term salmon calcitonin therapy

23 February 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1979.TB04110.X

Response of Paget's disease to porcine and salmon calcitonins: effects of long-term treatment.

23 February 2023

19

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1979.TB04110.X

Paget's bone disease treated with diphosphonate and calcitonin

23 February 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1979.TB04110.X

Amino acid sequence of salmon ultimobranchial calcitonin

23 February 2023

21

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1979.TB04110.X

An evaluation of antibodies and clinical resistance to salmon calcitonin

23 February 2023

22

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1979.TB04110.X

Paget's bone disease: response to human calcitonin in patients resistant to salmon calcitonin.

23 February 2023

23

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1979.TB04110.X

Development and significance of antibodies to salmon calcitonin in patients with Paget's disease on long-term treatment

23 February 2023

24

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1979.TB04110.X

Acute effects of calcitonin on bone formation in man.

23 February 2023

27

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1979.TB04110.X

23 February 2023

Identifiers

1 reference

13 September 2017

1 reference